Bioventus (BVS) Free Cash Flow (2020 - 2026)

Bioventus' Free Cash Flow history runs 7 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• Quarterly Free Cash Flow rose 141.67% year-over-year to $8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.7 million (up 320.71% YoY) and the FY2025 annual result came in at $72.1 million, up 90.83% from the prior year.
• Free Cash Flow was $8.4 million for Q1 2026 at Bioventus, down from $37.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $37.4 million in Q4 2025 and bottomed at -$21.1 million in Q2 2022.
• A 5-year average of $7.0 million and a median of $10.4 million in 2023 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2023 — Free Cash Flow surged 777.82% — and 2024, when it tumbled 672.88%.
• Bioventus' Free Cash Flow stood at $10.6 million in 2022, then declined by 2.24% to $10.4 million in 2023, then surged by 77.77% to $18.4 million in 2024, then surged by 102.88% to $37.4 million in 2025, then slumped by 77.53% to $8.4 million in 2026.
• Business Quant data shows BVS's Free Cash Flow at $8.4 million in Q1 2026, $37.4 million in Q4 2025, and $28.3 million in Q3 2025.